Brontekst bekijken van mp:V9.0.7 kwalificatie medicatiegegevens TA addendum


__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9.0.7 - TA: addendum inhoudelijke gegevens Kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || <div>Alle toedieningsafspraken van de patiënt, zonder aanvullende filter criteria (Antwoord: bericht met 6 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_907_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || <div>Toedieningsafspraken met een filter op product code (PRK 3956) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 toedienafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || <div>Toedieningafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_907_QA1" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || <div>Een antwoord zonder toedieningsafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder toedieningsafspraken)</div>
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_907_start_eind-BSC|| MBH_907_start_eind_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_907_start_duur-BSC|| MBH_907_start_duur_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_907_start_duur2-BSC|| MBH_907_start_duur2_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_907_chronisch-BSC|| MBH_907_chronisch_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_907_dosis_stuks-BSC|| MBH_907_dosis_stuks_TA-BSC
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_907_aanvullendeinstructie-VNK|| MBH_907_aanvullendeinstructie_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_907_toelichting-VNK|| MBH_907_toelichting_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_907_redenvanvoorschrijven-VNK|| MBH_907_redenvanvoorschrijven_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie'  zichtbaar is|| Aanvullende informatie|| MBH_907_aanvullendeinformatiewensen-VNK|| MBH_907_aanvullendeinformatiewensen_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| || Toedieningsweg|| MBH_907_Toedieningsweg-VNK|| MBH_907_Toedieningsweg_TA-VNK
|}
<section end=overview-MGB-2 />
=== Scenarioset 3===
<section begin=overview-MGB-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| || <div>Stop-toedienafspraak, met reden staken LET OP: stop afspraakvan scenario 2.1</div>|| || 
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_907_toelichting-VNK|| MBH_907_toelichting_TA_wijzigingmetMVE-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Wijziging toedieningsafspraak, met reden wijziging (stop-ma + nieuwe ma) LET OP: wijziging toedieningsafspraak van scenario 2.3</div>|| MBH_907_redenvanvoorschrijven-VNK|| MBH_907_redenvanvoorschrijven_TA_wijzigingzonderMVE-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.4 optioneel|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Onderbreken toedieningsafspraak LET OP: onderbreking toedieningsafspraak van scenario 2.4</div>|| MBH_907_aanvullendeinformatiewensen-VNK|| MBH_907_aanvullendeinformatiewensen_TA_onderbreken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</span></div>|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b</span></div>|| MBH_907_start_duur2-VNK|| MBH_907_start_duur2_TA_techstaken-VNK<br/>MBH_907_start_duur2_TA_anderePRK-VNK
|}
<section end=overview-MGB-3 />
=== Scenarioset 4===
<section begin=overview-MGB-4 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|4.1|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| Medicatieafspraak met lengte en gewicht|| MBH_907_Lengte_Gewicht-MLN|| MBH_907_Lengte_Gewicht_TA_1-MLN
|}
<section end=overview-MGB-4 />
=== Scenarioset 6===
<section begin=overview-MGB-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1 optioneel|| || Variabele frequentie|| MBH_907_variabelefrequentie-MSZ|| MBH_907_variabelefrequentie_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.2 optioneel|| || Interval|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.3 optioneel|| || Variabele hoeveelheid (1)|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.4 optioneel|| || Zonder keerdosis|| MBH_907_zonderkeerdosis-MSZ|| MBH_907_zonderkeerdosis_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.5 optioneel|| || Bijzondere keerdosis|| MBH_907_bijzonderekeerdosis-MSZ|| MBH_907_bijzonderekeerdosis_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.6 optioneel|| || Variabele hoeveelheid (2)|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.7*|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen|| MBH_907_tijdstippen-MSZ|| MBH_907_tijdstippen_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.8 optioneel|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.9*|| 	Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.10 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.11 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.12 optioneel|| || Variabele hoeveelheid en maximum|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.13 optioneel|| || Toedieningssnelheid|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.14 optioneel|| || Toedieningsduur|| MBH_907_toedieningsduur-MSZ|| MBH_907_toedieningsduur_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| || 
|}
<section end=overview-MGB-6 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_907_magistraalalleingredienten-TST|| MBH_907_magistraalalleingredienten_TA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.2 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_907_magistraalactieveingredient-TST|| MBH_907_magistraalactieveingredient_TA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_907_magistraal90miljoennr-TST|| MBH_907_magistraal90miljoennr_TA-TST
|}
<section end=overview-MGB-7 />
=== Scenarioset 9===
<section begin=overview-MGB-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|9.1a optioneel|| Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum)|| Logistieke verbruiksperiode|| MBH_907_logistiekeverbruiksperiode_start_eind-NCD|| MBH_907_logistiekeverbruiksperiode_start_eind_TA-NCD
|-style="vertical-align:top;|style="background-color: white;"
|9.1b optioneel|| || Logistieke verbruiksperiode|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.1c optioneel|| || Logistieke verbruiksperiode|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.2 optioneel|| Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden|| Herhalingen|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie|| MBH_907_afleverlocatie-NCD|| MBH_907_afleverlocatie_TA-NCD
|}
<section end=overview-MGB-9 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || ZI-nr geneesmiddel|| || 
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| <div>Alle toedieningsafspraken van de patiënt, zonder aanvullende filter criteria (Antwoord: bericht met 6 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_907_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| <div>Toedieningsafspraken met een filter op product code (PRK 3956) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 toedienafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| <div>Toedieningafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_907_QA1" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| <div>Een antwoord zonder toedieningsafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder toedieningsafspraken)</div>
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_907_start_eind-BSC|| MBH_907_start_eind_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2a|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_907_start_duur-BSC|| MBH_907_start_duur_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2b|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_907_start_duur2-BSC|| MBH_907_start_duur2_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_907_chronisch-BSC|| MBH_907_chronisch_TA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_907_dosis_stuks-BSC|| MBH_907_dosis_stuks_TA-BSC
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Aanvullende instructie|| MBH_907_aanvullendeinstructie-VNK|| MBH_907_aanvullendeinstructie_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Toelichting|| MBH_907_toelichting-VNK|| MBH_907_toelichting_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Reden van voorschrijven|| MBH_907_redenvanvoorschrijven-VNK|| MBH_907_redenvanvoorschrijven_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Aanvullende informatie|| MBH_907_aanvullendeinformatiewensen-VNK|| MBH_907_aanvullendeinformatiewensen_TA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Toedieningsweg|| MBH_907_Toedieningsweg-VNK|| MBH_907_Toedieningsweg_TA-VNK
|}
<section end=overview-MGR-2 />
=== Scenarioset 3===
<section begin=overview-MGR-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| <div>Stop-toedienafspraak, met reden staken LET OP: stop afspraakvan scenario 2.1</div>|| || 
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_907_toelichting-VNK|| MBH_907_toelichting_TA_wijzigingmetMVE-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| <div>Wijziging toedieningsafspraak, met reden wijziging (stop-ma + nieuwe ma) LET OP: wijziging toedieningsafspraak van scenario 2.3</div>|| MBH_907_redenvanvoorschrijven-VNK|| MBH_907_redenvanvoorschrijven_TA_wijzigingzonderMVE-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.4|| <div>Onderbreken toedieningsafspraak LET OP: onderbreking toedieningsafspraak van scenario 2.4</div>|| MBH_907_aanvullendeinformatiewensen-VNK|| MBH_907_aanvullendeinformatiewensen_TA_onderbreken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. LET OP: wijziging toedieningsafspraak van scenario 1.2b</span></div>|| MBH_907_start_duur2-VNK|| MBH_907_start_duur2_TA_techstaken-VNK<br/>MBH_907_start_duur2_TA_anderePRK-VNK
|}
<section end=overview-MGR-3 />
=== Scenarioset 4===
<section begin=overview-MGR-4 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|4.1|| Medicatieafspraak met lengte en gewicht|| MBH_907_Lengte_Gewicht-MLN|| MBH_907_Lengte_Gewicht_TA_1-MLN
|}
<section end=overview-MGR-4 />
=== Scenarioset 6===
<section begin=overview-MGR-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| Variabele frequentie|| MBH_907_variabelefrequentie-MSZ|| MBH_907_variabelefrequentie_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| Interval|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| Variabele hoeveelheid (1)|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| Zonder keerdosis|| MBH_907_zonderkeerdosis-MSZ|| MBH_907_zonderkeerdosis_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| Bijzondere keerdosis|| MBH_907_bijzonderekeerdosis-MSZ|| MBH_907_bijzonderekeerdosis_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| Variabele hoeveelheid (2)|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.7|| Tijdstippen|| MBH_907_tijdstippen-MSZ|| MBH_907_tijdstippen_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Weekdagen|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Dagdeel|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Cyclisch schema|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Afbouw schema en doseerduur|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| Variabele hoeveelheid en maximum|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| Toedieningssnelheid|| || 
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| Toedieningsduur|| MBH_907_toedieningsduur-MSZ|| MBH_907_toedieningsduur_TA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Zo nodig|| || 
|}
<section end=overview-MGR-6 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_907_magistraalalleingredienten-TST|| MBH_907_magistraalalleingredienten_TA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_907_magistraalactieveingredient-TST|| MBH_907_magistraalactieveingredient_TA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_907_magistraal90miljoennr-TST|| MBH_907_magistraal90miljoennr_TA-TST
|}
<section end=overview-MGR-7 />
=== Scenarioset 9===
<section begin=overview-MGR-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|9.1a|| Logistieke verbruiksperiode|| MBH_907_logistiekeverbruiksperiode_start_eind-NCD|| MBH_907_logistiekeverbruiksperiode_start_eind_TA-NCD
|-style="vertical-align:top;|style="background-color: white;"
|9.1b|| Logistieke verbruiksperiode|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.1c|| Logistieke verbruiksperiode|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.2|| Herhalingen|| || 
|-style="vertical-align:top;|style="background-color: white;"
|9.3|| Afleverlocatie|| MBH_907_afleverlocatie-NCD|| MBH_907_afleverlocatie_TA-NCD
|}
<section end=overview-MGR-9 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| ZI-nr geneesmiddel|| || 
|}
<section end=overview-MGR-10 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-1 />
==== Scenario 0.1 - MBH_907_QA1-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA1_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA1_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 20 dagen om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_907_QA2-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA2_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA2_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 100 dagen om 09:04:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, Vanaf <T-100D{00:00:00}> t/m T-72D{23:59:59}, 1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA2_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_907_QA3-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA3_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA3_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 09:10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_907_QA4-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA4_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA4_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 10 dagen om 09:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_907_QA6-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA6_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA6_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 5 dagen om 09:18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, Vanaf <T-5D{00:00:00}> t/m <T+1D{23:59:59}>, 2 maal per dag 2 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA6_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA6-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-1 /><section end=mg-mgr-mg-TA-Scenarioset0-0-1 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-2 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-2 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-2 />
==== Scenario 0.2 - MBH_907_QA1-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA1_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA1_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 20 dagen om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-2 /><section end=mg-mgr-mg-TA-Scenarioset0-0-2 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-3optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-3optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-3optioneel />
==== Scenario 0.3 - MBH_907_QA4-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA4_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA4_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 10 dagen om 09:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-3optioneel /><section end=mg-mgr-mg-TA-Scenarioset0-0-3optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-4 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-4 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-4 />
==== Scenario 0.4 - MBH_907_QA1-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA1_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA1_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 20 dagen om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA1_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA1_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 20 dagen om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_907_QA3-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA3_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA3_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 09:10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_907_QA4-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA4_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA4_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 10 dagen om 09:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-4 /><section end=mg-mgr-mg-TA-Scenarioset0-0-4 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-5 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-5 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-5 />
==== Scenario 0.5 - MBH_907_QA2-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA2_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA2_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 100 dagen om 09:04:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, Vanaf <T-100D{00:00:00}> t/m T-72D{23:59:59}, 1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA2_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA2-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_907_QA3-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA3_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA3_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 09:10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_907_QA5-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_QA5_TA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_QA5_TA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 09:15:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, Vanaf <T-50D{00:00:00}>, gedurende 7 dagen, 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_QA5_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_QA5-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-5 /><section end=mg-mgr-mg-TA-Scenarioset0-0-5 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-6 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-6 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-6 />
==== Scenario 0.6 - MBH_907_QA1-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_907_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="5" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_907_QA1_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T - 20 dagen om 08:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="9"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_907_QA1-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_907_QA3-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_907_QA3_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="5" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_907_QA3_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 08:10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="9"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_907_QA3-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_907_QA4-JNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Medicatieafspraak MBH_907_QA4_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="5" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_907_QA4_MA-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T - 10 dagen om 08:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="9"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van  Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 3 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_907_QA4-JNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-6 /><section end=mg-mgr-mg-TA-Scenarioset0-0-6 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-7 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-7 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-7 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-7 /><section end=mg-mgr-mg-TA-Scenarioset0-0-7 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-TA-Scenarioset0-0-8 /><section begin=patient-mg-mgr-mg-TA-Scenarioset0-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 mei 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset0-0-8 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset0-0-8 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset0-0-8 /><section end=mg-mgr-mg-TA-Scenarioset0-0-8 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mgr-mg-TA-Scenarioset1-1-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset1-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jan 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset1-1-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset1-1-1 />
==== Scenario 1.1 - MBH_907_start_eind-BSC====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_start_eind_TA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_start_eind_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 12:20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaar HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, Vanaf <T+0D{00:00:00}> t/m <T+5D{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_start_eind_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_start_eind-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset1-1-1 /><section end=mg-mgr-mg-TA-Scenarioset1-1-1 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mgr-mg-TA-Scenarioset1-1-2a /><section begin=patient-mg-mgr-mg-TA-Scenarioset1-1-2a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jan 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset1-1-2a /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset1-1-2a />
==== Scenario 1.2a - MBH_907_start_duur-BSC====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_start_duur_TA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_start_duur_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 12:30:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, gedurende 3 weken, Vanaf <T+0D{00:00:00}>, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_start_duur_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_start_duur-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset1-1-2a /><section end=mg-mgr-mg-TA-Scenarioset1-1-2a />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mgr-mg-TA-Scenarioset1-1-2b /><section begin=patient-mg-mgr-mg-TA-Scenarioset1-1-2b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jan 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset1-1-2b /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset1-1-2b />
==== Scenario 1.2b - MBH_907_start_duur2-BSC====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_start_duur2_TA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_start_duur2_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 60 dagen om 12:30:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, Vanaf <T-60D{00:00:00}>, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_start_duur2_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_start_duur2-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset1-1-2b /><section end=mg-mgr-mg-TA-Scenarioset1-1-2b />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mgr-mg-TA-Scenarioset1-1-3 /><section begin=patient-mg-mgr-mg-TA-Scenarioset1-1-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jan 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset1-1-3 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset1-1-3 />
==== Scenario 1.3 - MBH_907_chronisch-BSC====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_chronisch_TA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_chronisch_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 30 dagen om 12:32:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, Vanaf <T-30D{00:00:00}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_chronisch_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_chronisch-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset1-1-3 /><section end=mg-mgr-mg-TA-Scenarioset1-1-3 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mgr-mg-TA-Scenarioset1-1-4 /><section begin=patient-mg-mgr-mg-TA-Scenarioset1-1-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jan 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset1-1-4 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset1-1-4 />
==== Scenario 1.4 - MBH_907_dosis_stuks-BSC====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_dosis_stuks_TA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_dosis_stuks_TA-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 130 dagen om 12:35:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 130 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 101 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, Vanaf <T-130D{00:00:00}> t/m <T-101D{00:00:00}>, 2 maal per dag 1 inhalatie, inhalatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_dosis_stuks_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_dosis_stuks-BSC (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset1-1-4 /><section end=mg-mgr-mg-TA-Scenarioset1-1-4 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mgr-mg-TA-Scenarioset2-2-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset2-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset2-2-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset2-2-1 />
==== Scenario 2.1 - MBH_907_aanvullendeinstructie-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_aanvullendeinstructie_TA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_aanvullendeinstructie_TA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 4 maanden om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 8 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, Vanaf <T-4M{00:00:00}> t/m <T+8M{23:59:59}>, 1 maal per dag 1 stuk, Bij het eten innemen, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_aanvullendeinstructie_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_aanvullendeinstructie-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset2-2-1 /><section end=mg-mgr-mg-TA-Scenarioset2-2-1 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mgr-mg-TA-Scenarioset2-2-2 /><section begin=patient-mg-mgr-mg-TA-Scenarioset2-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset2-2-2 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset2-2-2 />
==== Scenario 2.2 - MBH_907_toelichting-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_toelichting_TA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_toelichting_TA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 21 dagen om 09:02:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|LASIX TABLET 40MG (code = '220515' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, Vanaf <T-21D{00:00:00}>, 1 maal daags 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|In overleg met specialist
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_toelichting_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_toelichting-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset2-2-2 /><section end=mg-mgr-mg-TA-Scenarioset2-2-2 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mgr-mg-TA-Scenarioset2-2-3 /><section begin=patient-mg-mgr-mg-TA-Scenarioset2-2-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset2-2-3 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset2-2-3 />
==== Scenario 2.3 - MBH_907_redenvanvoorschrijven-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_redenvanvoorschrijven_TA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_redenvanvoorschrijven_TA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 13 dagen om 09:05:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, Vanaf <T-13D{00:00:00}> t/m <T+14D{23:59:59}>, 1 maal per week 5 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per week 5 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_redenvanvoorschrijven_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_redenvanvoorschrijven-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset2-2-3 /><section end=mg-mgr-mg-TA-Scenarioset2-2-3 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mgr-mg-TA-Scenarioset2-2-4 /><section begin=patient-mg-mgr-mg-TA-Scenarioset2-2-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset2-2-4 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset2-2-4 />
==== Scenario 2.4 - MBH_907_aanvullendeinformatiewensen-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_aanvullendeinformatiewensen_TA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen_TA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 5 dagen om 09:06:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, Vanaf <T-4D{00:00:00}> t/m <T+5D{23:59:59}>, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende informatie
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset2-2-4 /><section end=mg-mgr-mg-TA-Scenarioset2-2-4 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mgr-mg-TA-Scenarioset2-2-5 /><section begin=patient-mg-mgr-mg-TA-Scenarioset2-2-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset2-2-5 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset2-2-5 />
==== Scenario 2.5 - MBH_907_Toedieningsweg-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_Toedieningsweg_TA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_Toedieningsweg_TA-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 5 dagen om 09:15:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, Vanaf <T-5D{00:00:00}> t/m <T+2D{23:59:59}>, 2 maal per dag 1 druppel, In het rechter oog, oculair
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 druppel
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende informatie
|style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_Toedieningsweg_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_Toedieningsweg-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset2-2-5 /><section end=mg-mgr-mg-TA-Scenarioset2-2-5 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-TA-Scenarioset3-3-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset3-3-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset3-3-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset3-3-1 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset3-3-1 /><section end=mg-mgr-mg-TA-Scenarioset3-3-1 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-TA-Scenarioset3-3-2 /><section begin=patient-mg-mgr-mg-TA-Scenarioset3-3-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset3-3-2 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset3-3-2 />
==== Scenario 3.2 - MBH_907_toelichting-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_toelichting_TA_wijzigingmetMVE-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_toelichting_TA_wijzigingmetMVE-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 2 dagen om 09:02:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, Vanaf <T-2D{00:00:00}> 1 maal daags 2 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_toelichting_MA_wijzigingmetVV-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_toelichting-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset3-3-2 /><section end=mg-mgr-mg-TA-Scenarioset3-3-2 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-TA-Scenarioset3-3-3 /><section begin=patient-mg-mgr-mg-TA-Scenarioset3-3-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset3-3-3 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset3-3-3 />
==== Scenario 3.3 - MBH_907_redenvanvoorschrijven-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_redenvanvoorschrijven_TA_wijzigingzonderMVE-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_redenvanvoorschrijven_TA_wijzigingzonderMVE-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 1 dag om 09:10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '42609' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, Vanaf <T-1D{00:00:00}> t/m <T+14D{23:59:59}>, 1 maal per week 4 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per week 4 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_redenvanvoorschrijven-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset3-3-3 /><section end=mg-mgr-mg-TA-Scenarioset3-3-3 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-TA-Scenarioset3-3-4optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset3-3-4optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset3-3-4optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset3-3-4optioneel />
==== Scenario 3.4 - MBH_907_aanvullendeinformatiewensen-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_aanvullendeinformatiewensen_TA_onderbreken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen_TA_onderbreken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 1 dag om 19:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Stoptype
|style="background-color: white;"|Tijdelijk (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, Vanaf <T+1D{00:00:00}> t/m <T+1D{23:59:59}>, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende informatie
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen_MA_onderbreken-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_aanvullendeinformatiewensen-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset3-3-4optioneel /><section end=mg-mgr-mg-TA-Scenarioset3-3-4optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-TA-Scenarioset3-3-5 /><section begin=patient-mg-mgr-mg-TA-Scenarioset3-3-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 feb 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset3-3-5 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset3-3-5 />
==== Scenario 3.5 - MBH_907_start_duur2-VNK====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_start_duur2_TA_techstaken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_start_duur2_TA_techstaken-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 12:30:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Stoptype
|style="background-color: white;"|Definitief (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '5227' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|(code = '' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende informatie
|style="background-color: white;"|Niet leverbaar (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_start_duur2_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_start_duur2-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_start_duur2_TA_anderePRK-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_start_duur2_TA_anderePRK-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 50 dagen om 12:35:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden afspraak
|style="background-color: white;"|Pantozol niet leverbaar
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|OMEPRAZOL APOTEX CAPSULE MSR 20MG (code = '1480960' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = '60062' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 20MG (code = ' 114529' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 28 dagen, Vanaf <T-50D{00:00:00}>, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Aanvullende informatie
|style="background-color: white;"|Niet leverbaar (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Preferentie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_start_duur2_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_start_duur2-VNK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset3-3-5 /><section end=mg-mgr-mg-TA-Scenarioset3-3-5 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 4 (Lengte/Gewicht)==
<section begin=mg-mgr-mg-TA-Scenarioset4-4-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset4-4-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Molenaars
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910449 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 jun 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset4-4-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset4-4-1 />
==== Scenario 4.1 - MBH_907_Lengte_Gewicht-MLN====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_Lengte_Gewicht_TA_1-MLN
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_Lengte_Gewicht_TA_1-MLN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T - 1 jaar om 08:05:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T - 1 jaar
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T - 1 jaar, Vanaf <T-1Y{00:00:00}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_Lengte_Gewicht_MA_1-MLN
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_Lengte_Gewicht-MLN (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset4-4-1 /><section end=mg-mgr-mg-TA-Scenarioset4-4-1 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-1optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-1optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-1optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-1optioneel />
==== Scenario 6.1 - MBH_907_variabelefrequentie-MSZ====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_variabelefrequentie_TA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_variabelefrequentie_TA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 09:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, Vanaf <T+0D{00:00:00}> t/m <T+16D{23:59:59}>, 1 à 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_variabelefrequentie_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_variabelefrequentie-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-1optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-1optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-2optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-2optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-2optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-2optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-2optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-3optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-3optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-3optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-3optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-3optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-4optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-4optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-4optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-4optioneel />
==== Scenario 6.4 - MBH_907_zonderkeerdosis-MSZ====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_zonderkeerdosis_TA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_zonderkeerdosis_TA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 09:12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, Vanaf <T+0D{00:00:00}> t/m <T+28D{23:59:59}>, 3 maal per dag aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_zonderkeerdosis_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_zonderkeerdosis-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-4optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-4optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-5optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-5optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-5optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-5optioneel />
==== Scenario 6.5 - MBH_907_bijzonderekeerdosis-MSZ====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_bijzonderekeerdosis_TA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_bijzonderekeerdosis_TA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 09:15:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, Vanaf <T+0D{18:00:00}> t/m <T+28D{23:59:59}>, 2 maal per dag 0.5 tablet
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 0.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_bijzonderekeerdosis_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_bijzonderekeerdosis-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-5optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-5optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-6optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-6optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-6optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-6optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-6optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-6optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-7 /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-7 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-7 />
==== Scenario 6.7 - MBH_907_tijdstippen-MSZ====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_tijdstippen_TA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_tijdstippen_TA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 09:24:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, Vanaf <T+0D{00:00:00}> t/m <T+14D{23:59:59}>, 3 maal daags 1 tablet, (8:00, 14:00, 20:00) oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|elke dag om 08:00:00, 14:00:00 en 20:00:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_tijdstippen_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_tijdstippen-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-7 /><section end=mg-mgr-mg-TA-Scenarioset6-6-7 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-8optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-8optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-8optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-8optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-8optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-8optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-9 /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-9 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-9 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-9 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-9 /><section end=mg-mgr-mg-TA-Scenarioset6-6-9 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-10optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-10optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-10optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-10optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-10optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-10optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-11optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-11optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-11optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-11optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-11optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-11optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-12optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-12optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-12optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-12optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-12optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-12optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-13optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-13optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-13optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-13optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-13optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-13optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-14optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-14optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-14optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-14optioneel />
==== Scenario 6.14 - MBH_907_toedieningsduur-MSZ====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_toedieningsduur_TA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_toedieningsduur_TA-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 09:49:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, Vanaf <T+0D{00:00:00}>, eenmaal daags 1 pleister aanbrengen gedurende 16 uur, transdermaal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_toedieningsduur_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_toedieningsduur-MSZ (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-14optioneel /><section end=mg-mgr-mg-TA-Scenarioset6-6-14optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-TA-Scenarioset6-6-15 /><section begin=patient-mg-mgr-mg-TA-Scenarioset6-6-15 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset6-6-15 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset6-6-15 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset6-6-15 /><section end=mg-mgr-mg-TA-Scenarioset6-6-15 />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-TA-Scenarioset7-7-1optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset7-7-1optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|5 mei 1970
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset7-7-1optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset7-7-1optioneel />
==== Scenario 7.1 - MBH_907_magistraalalleingredienten-TST====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_magistraalalleingredienten_TA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_magistraalalleingredienten_TA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 13:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 31 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr           Regel: UREUM 10gr           Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"|10 gram per  100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"|90 gram per  100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Vanaf <T+0D{00:00:00}> t/m <T+31D{23:59:59}> zo nodig, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|zo nodig
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_magistraalalleingredienten_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_magistraalalleingredienten-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset7-7-1optioneel /><section end=mg-mgr-mg-TA-Scenarioset7-7-1optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-TA-Scenarioset7-7-2optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset7-7-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|5 mei 1970
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset7-7-2optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset7-7-2optioneel />
==== Scenario 7.2 - MBH_907_magistraalactieveingredient-TST====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_magistraalactieveingredient_TA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_magistraalactieveingredient_TA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 13:05:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 70 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"|80 gram per  100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, Vanaf <T+1D{00:00:00}> t/m <T+70D{23:59:59}>, 1x daags, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_magistraalactieveingredient_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_magistraalactieveingredient-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset7-7-2optioneel /><section end=mg-mgr-mg-TA-Scenarioset7-7-2optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-TA-Scenarioset7-7-3optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset7-7-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|5 mei 1970
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset7-7-3optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset7-7-3optioneel />
==== Scenario 7.3 - MBH_907_magistraal90miljoennr-TST====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_magistraal90miljoennr_TA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_magistraal90miljoennr_TA-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 13:08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr           Regel: UREUM 10gr           Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"|10 gram per  100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, Vanaf <T+0D{00:00:00}> t/m <T+30D{23:59:59}>, 1x per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_magistraal90miljoennr_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_magistraal90miljoennr-TST (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset7-7-3optioneel /><section end=mg-mgr-mg-TA-Scenarioset7-7-3optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 9 (diversen TA)==
<section begin=mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-Incident-A
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990159 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jan 1950
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel />
==== Scenario 9.1a - MBH_907_logistiekeverbruiksperiode_start_eind-NCD====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_logistiekeverbruiksperiode_start_eind_TA-NCD
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_logistiekeverbruiksperiode_start_eind_TA-NCD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 12:00:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen, tot en met T + 12 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 12 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 12 maanden, Vanaf <T+10D{00:00:00}> t/m <T+12M{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_logistiekeverbruiksperiode_start_eind_MA-NCD
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_logistiekeverbruiksperiode_start_eind-NCD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel /><section end=mg-mgr-mg-TA-Scenarioset9-9-1aoptioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 9 (diversen TA)==
<section begin=mg-mgr-mg-TA-Scenarioset9-9-1boptioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset9-9-1boptioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-Incident-A
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990159 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jan 1950
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset9-9-1boptioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1boptioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1boptioneel /><section end=mg-mgr-mg-TA-Scenarioset9-9-1boptioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 9 (diversen TA)==
<section begin=mg-mgr-mg-TA-Scenarioset9-9-1coptioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset9-9-1coptioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-Incident-A
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990159 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jan 1950
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset9-9-1coptioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1coptioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset9-9-1coptioneel /><section end=mg-mgr-mg-TA-Scenarioset9-9-1coptioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 9 (diversen TA)==
<section begin=mg-mgr-mg-TA-Scenarioset9-9-2optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset9-9-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-Incident-A
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990159 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jan 1950
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset9-9-2optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset9-9-2optioneel /><section end=mbhs-mg-mgr-mg-TA-Scenarioset9-9-2optioneel /><section end=mg-mgr-mg-TA-Scenarioset9-9-2optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 9 (diversen TA)==
<section begin=mg-mgr-mg-TA-Scenarioset9-9-3optioneel /><section begin=patient-mg-mgr-mg-TA-Scenarioset9-9-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-Incident-A
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990159 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jan 1950
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset9-9-3optioneel /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset9-9-3optioneel />
==== Scenario 9.3 - MBH_907_afleverlocatie-NCD====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Toedieningsafspraak MBH_907_afleverlocatie_TA-NCD
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_907_afleverlocatie_TA-NCD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afspraakdatum
|style="background-color: white;"|T om 12:07:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, Vanaf <T+1D{00:00:00}> t/m <T+10D{23:59:59}>, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_907_afleverlocatie_MA-NCD
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_907_afleverlocatie-NCD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=mbhs-mg-mgr-mg-TA-Scenarioset9-9-3optioneel /><section end=mg-mgr-mg-TA-Scenarioset9-9-3optioneel />
== MP KWALIFICATIE Medicatiegegevens TA Scenarioset 10 (ZI)==
<section begin=mg-mgr-mg-TA-Scenarioset10-10-1 /><section begin=patient-mg-mgr-mg-TA-Scenarioset10-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;" 
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|B.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"  
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Kester
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999911557 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|2 aug 1954
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mgr-mg-TA-Scenarioset10-10-1 /><section begin=mbhs-mg-mgr-mg-TA-Scenarioset10-10-1 /><section end=mbhs-mg-mgr-mg-TA-Scenarioset10-10-1 /><section end=mg-mgr-mg-TA-Scenarioset10-10-1 />

[[Categorie:Kwalificatie]]